Varian Medical Systems Inc (VAR)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Varian Medical Systems Inc (VAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013183
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Varian Medical Systems Inc (Varian) designs, manufactures and sells equipment and software for the diagnosis and treatment of cancer and other medical conditions through radiotherapy, radiosurgery, proton therapy and brachytherapy. Its major products include brachytherapy afterloaders, linear accelerators, treatment simulation and verification equipment, X-ray tubes, high voltage connectors, and flat panel digital image detectors. Varian also offers software solutions for information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support and practice management. The company’s products find application in fluoroscopic imaging, mammography, computed tomography, cargo scanning, computer-aided diagnostics and other industrial applications. Varian offers its products to healthcare agencies, physicians’ offices, university research and community hospitals, and private and governmental institutions. The company has presence in North America, Europe, Asia-Pacific, the Middle East and Africa. Varian is headquartered in Palo Alto, California, the US.

Varian Medical Systems Inc (VAR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Varian Medical Systems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Varian Medical Systems Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Varian Medical Systems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Varian Medical Systems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Varian Medical Systems Inc, Medical Devices Deals, 2011 to YTD 2017 10
Varian Medical Systems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Varian Medical Systems Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Varian Medical Systems Completes Acquisition Of Certain Assets From Velocity Medical Solutions 12
Venture Financing 14
Fusion Pharma Raises Additional USD17 Million in Series A Financing 14
Grail Raises USD914 Million in First Tranche of Series B Financing 16
Partnerships 18
DNAmito Enters into Development Agreement with Varian Medical Systems 18
Cancer Research UK Enters Into Co-Development Agreement With Centella Therapeutics And Cancer Research Technology 19
Licensing Agreements 20
Centella Therapeutics Enters Into Licensing Agreement With Auckland UniServices For CEN-209 20
Acquisition 21
Varian Medical Systems to Acquire Claymount Assemblies 21
Varian Medical Systems Acquires Majority Stake in MeVis Medical Solutions for USD37.4 Million in Tender Offer 22
Varian Medical Systems Inc – Key Competitors 24
Varian Medical Systems Inc – Key Employees 25
Varian Medical Systems Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Joint Venture 29
Recent Developments 30
Strategy And Business Planning 30
Apr 04, 2017: Varian Medical Systems Establishes Direct Operation in South Africa 30
Jan 30, 2017: Varian Announces Successful Separation of Imaging Components Business 31
Mar 03, 2016: Varian Medical Systems Breaks Ground On New Brazil Facility 32
Financial Announcements 33
Jul 26, 2017: Varian Medical Systems Reports Third Quarter Fiscal Year 2017 Results Highlighting Growth in Backlog and Improvements in both Gross Margin and Working Capital 33
Apr 26, 2017: Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2017 34
Jan 25, 2017: Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2017 35
Oct 26, 2016: Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2016 37
Jul 27, 2016: Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2016 39
Apr 27, 2016: Varian Medical Systems Reports Results For Second Quarter Of Fiscal Year 2016 40
Jan 27, 2016: Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2016 41
Corporate Communications 42
Apr 05, 2017: Varian Medical Systems Names New CFO 42
Mar 01, 2017: José Baselga and Jean-Luc Butel Appointed to Board of Directors of Varian Medical Systems 43
Oct 26, 2016: Elisha W. Finney Announces Plan to Retire as CFO of Varian Medical Systems 44
Aug 22, 2016: Judy Bruner Appointed to Board of Directors of Varian Medical Systems; Venkatraman Thyagarajan Retires from Varian Board 45
Mar 07, 2016: Varian Medical Systems Announces Particle Therapy Scientific Advisory Board 46
Legal and Regulatory 47
Apr 03, 2017: Varian Medical Systems and Elekta Settle Patent Litigation 47
Other Significant Developments 48
Jul 21, 2016: Varian Medical Systems Announces Company Name For Imaging Components Business 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
Varian Medical Systems Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Varian Medical Systems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Varian Medical Systems Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Varian Medical Systems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Varian Medical Systems Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Varian Medical Systems Inc, Medical Devices Deals, 2011 to YTD 2017 10
Varian Medical Systems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Varian Medical Systems Completes Acquisition Of Certain Assets From Velocity Medical Solutions 12
Fusion Pharma Raises Additional USD17 Million in Series A Financing 14
Grail Raises USD914 Million in First Tranche of Series B Financing 16
DNAmito Enters into Development Agreement with Varian Medical Systems 18
Cancer Research UK Enters Into Co-Development Agreement With Centella Therapeutics And Cancer Research Technology 19
Centella Therapeutics Enters Into Licensing Agreement With Auckland UniServices For CEN-209 20
Varian Medical Systems to Acquire Claymount Assemblies 21
Varian Medical Systems Acquires Majority Stake in MeVis Medical Solutions for USD37.4 Million in Tender Offer 22
Varian Medical Systems Inc, Key Competitors 24
Varian Medical Systems Inc, Key Employees 25
Varian Medical Systems Inc, Subsidiaries 27
Varian Medical Systems Inc, Joint Venture 29

★海外企業調査レポート[Varian Medical Systems Inc (VAR)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • OCI Co Ltd (010060):電力:M&Aディール及び事業提携情報
    Summary OCI Co Ltd (OCI) is a green energy and chemical company. It manufactures and sells a wide range of inorganic chemicals, coal and petrochemicals, and fine chemicals. The company’s product portfolio includes toluene di-isocyanate (TDI), hydrogen peroxide, carbon black, pitch, sodium percarbona …
  • Ternium SA:戦略・SWOT・企業財務分析
    Ternium SA - Strategy, SWOT and Corporate Finance Report Summary Ternium SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Guangshen Railway Company Limited:企業の戦略・SWOT・財務情報
    Guangshen Railway Company Limited - Strategy, SWOT and Corporate Finance Report Summary Guangshen Railway Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • BNY Mellon Wealth Management:企業の戦略・SWOT・財務情報
    BNY Mellon Wealth Management - Strategy, SWOT and Corporate Finance Report Summary BNY Mellon Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Bajaj Allianz Life Insurance Company Ltd:企業の戦略・SWOT・財務情報
    Bajaj Allianz Life Insurance Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Bajaj Allianz Life Insurance Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Pioneer Natural Resources Co (PXD):企業の財務・戦略的SWOT分析
    Pioneer Natural Resources Co (PXD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Praxair Inc (PX)-エネルギー分野:企業M&A・提携分析
    Summary Praxair Inc (Praxair) is a producer and supplier of industrial gases. The company offers atmospheric gases including oxygen, nitrogen, argon and rare gases, and process gases such as carbon dioxide, helium, hydrogen, electronic gases, specialty gases and acetylene. It also designs and builds …
  • Hog’s Breath Cafe (Australia) Pty Ltd:企業の戦略・SWOT・財務情報
    Hog's Breath Cafe (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Hog's Breath Cafe (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Antrim Energy Inc. (AEN)-石油・ガス分野:企業M&A・提携分析
    Summary Antrim Energy Inc. (Antrim Energy) is an oil and gas exploration and production company. It conducts the acquisition, exploration, development and production of oil and natural gas properties. The company carries out its operations in the UK North Sea and Ireland. In UK, the company holds op …
  • Philippine Long Distance Telephone Company:企業の戦略・SWOT・財務情報
    Philippine Long Distance Telephone Company - Strategy, SWOT and Corporate Finance Report Summary Philippine Long Distance Telephone Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • International Personal Finance plc:企業の戦略・SWOT・財務情報
    International Personal Finance plc - Strategy, SWOT and Corporate Finance Report Summary International Personal Finance plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Global Blood Therapeutics Inc (GBT):企業の財務・戦略的SWOT分析
    Summary Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The company's lead drug candidate GBT440 is an oral, small molecule drug for the treatment o …
  • NORDSEE GmbH.:戦略・SWOT・企業財務分析
    NORDSEE GmbH. - Strategy, SWOT and Corporate Finance Report Summary NORDSEE GmbH. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Pakistan Oilfields Ltd (POL):企業の財務・戦略的SWOT分析
    Pakistan Oilfields Ltd (POL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Full House Resorts, Inc.:企業の戦略・SWOT・財務情報
    Full House Resorts, Inc. - Strategy, SWOT and Corporate Finance Report Summary Full House Resorts, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Mita-Teknik AS:企業の戦略的SWOT分析
    Mita-Teknik AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Asian American Medical Group Ltd (AJJ):企業の財務・戦略的SWOT分析
    Asian American Medical Group Ltd (AJJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Monsanto Company (MON)-製薬・医療分野:企業M&A・提携分析
    Summary Monsanto Company (Monsanto) is an agricultural products manufacturing company. It develops and delivers agricultural products to support farmers all around the world. The company develops biotechnology traits that assist farmers in controlling insects and weeds. Monsanto also provides other …
  • Petroleo Brasileiro SA (PETR4)-エネルギー分野:企業M&A・提携分析
    Summary Petroleo Brasileiro S.A. (Petrobras) is an integrated oil and gas company. Its major businesses include exploration and production, refining, marketing , trade and transportation of oil and gas. The company also conducts biofuel, petrochemical, natural gas, electricity and chemical-gas busin …
  • Daktronics Inc (DAKT):企業の財務・戦略的SWOT分析
    Daktronics Inc (DAKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆